Indicators

Markets:

News

Latest News about NPCE

Recent news which mentions NPCE

< Previous 1 2 3 Next >

12 Health Care Stocks Moving In Monday's After-Market Session

January 02, 2023

$10 Million Bet On Canoo? Check Out These 3 Stocks Under $3 Insiders Are Buying

November 25, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

November 24, 2022

Stocks That Hit 52-Week Lows On Monday

November 14, 2022

Stocks That Hit 52-Week Lows On Tuesday

October 25, 2022

NeuroPace's Return On Capital Employed Insights

September 07, 2022

NeuroPace, Inc. (NPCE) Q2 2022 Earnings Call Transcript

August 12, 2022

NeuroPace: Q2 Earnings Insights

August 11, 2022

Earnings Scheduled For August 11, 2022

August 11, 2022

89 Biggest Movers From Friday

June 21, 2022

Stocks That Hit 52-Week Lows On Thursday

June 02, 2022

5 Analysts Have This to Say About NeuroPace

May 13, 2022

NeuroPace, Inc. (NPCE) Q1 2022 Earnings Call Transcript

May 13, 2022

Recap: NeuroPace Q1 Earnings

May 12, 2022

Expert Ratings For NeuroPace

April 06, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022

April 06, 2022

NeuroPace, Inc. (NPCE) Q4 2021 Earnings Call Transcript

March 10, 2022

Earnings Scheduled For March 10, 2022

March 10, 2022

Stocks That Hit 52-Week Lows On Monday

February 07, 2022

Stocks That Hit 52-Week Lows On Friday

February 04, 2022

Stocks That Hit 52-Week Lows On Wednesday

February 02, 2022

The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award

January 12, 2022

58 Biggest Movers From Yesterday

December 14, 2021

50 Biggest Movers From Yesterday

November 30, 2021

12 Health Care Stocks Moving In Thursday's Intraday Session

November 11, 2021

NeuroPace, Inc. (NPCE) Q3 2021 Earnings Call Transcript

November 11, 2021

The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts

November 11, 2021

Looking Into NeuroPace's Return On Capital Employed

November 10, 2021

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug

September 29, 2021

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data

September 21, 2021

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.